Initiation of Guideline-Matched Oral Anticoagulant in Atrial Fibrillation-Related Stroke.

ABSTRACT:

Background and purpose

To evaluate the outcome events and bleeding complications of the European Society of Cardiology (ESC) guideline-matched oral anticoagulant therapy for patients with acute ischemic stroke and atrial fibrillation (AF).

Methods

Patients with acute ischemic stroke and AF from a nationwide multicenter registry (Korean ATrial fibrillaTion EvaluatioN regisTry in Ischemic strOke patieNts [K-ATTENTION]) between January 2013 and December 2015 were included in the study. Patients were divided into the ESC guideline-matched and the non-matched groups. The primary outcome was recurrence of any stroke during the 90-day follow-up period. Secondary outcomes were major adverse cerebrovascular and cardiovascular events, ischemic stroke, intracranial hemorrhage, acute co

SUBMITTER: Eun MY 

PROVIDER: S-EPMC7900398 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature